Search results
NanoViricides completes Phase 1 trial of lead asset NV-387
Proactive Investors· 3 days agoThe company, a leader in broad-spectrum antiviral nanomedicines, is developing NV-387 as a...
Mpox: why the virus’s continued, rapid mutation since the 2022 global outbreak remains a concern
The Conversation· 4 days agoIn 2022, as the world was slowly beginning to recover from the worst of the COVID-19 pandemic, an outbreak of mpox – then still called monkeypox – began spreading at an alarming ...
First fetus-to-fetus transplant demonstrated in rats
Nature· 3 days agoThe tissue developed into functioning kidneys and produced urine.
Earnings call: QIAGEN posts mixed Q1 results, reaffirms 2024 outlook By Investing.com
Investing.com· 2 days agoQIAGEN N.V. (NYSE: QGEN) reported a 5% decline in net sales for the first quarter of 2024, totaling...
A new form of mpox that may spread more easily found in Congo's biggest outbreak
McComb Enterprise-Journal· 11 hours agoA family nurse practitioner prepares a syringe with the Mpox vaccine for inoculating a patient at a vaccination site in the Brooklyn borough of New York, on Tuesday, Aug. 30, 2022. Scientists ...
Ohio ranks fifth in the nation for storm-caused power outages. Is it because we don’t bury power...
The Cleveland Plain Dealer· 6 days agoEditor Chris Quinn hosts our daily half-hour news podcast, with editorial board member Lisa Garvin, impact editor Leila Atassi and content director Laura Johnston.
Earnings call: QIAGEN posts mixed Q1 results, reaffirms 2024 outlook
Investing.com· 3 days agoQIAGEN N.V. (NYSE: QGEN) reported a 5% decline in net sales for the first quarter of 2024, totaling...